Volume 5, Issue 3 (12-2023)
Tabari Biomed Stu Res J 2023, 5(3): 13-20 |
Back to browse issues page
Ethics code: IR. MAZUMS. REC.1400.10503
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Khoshgoeian A, Hosseini-khah Z, Kashi Z, Movahedirad M, Bahar A. Association between ABO Blood Groups and Thyroid Dysfunction. Tabari Biomed Stu Res J 2023; 5 (3) :13-20
URL: http://tbsrj.mazums.ac.ir/article-1-3815-en.html
URL: http://tbsrj.mazums.ac.ir/article-1-3815-en.html
Amirhossein Khoshgoeian1 
, Zahra Hosseini-khah1 , Zahra Kashi1 , Marzieh Movahedirad1 , Adele Bahar * 1
, Zahra Hosseini-khah1 , Zahra Kashi1 , Marzieh Movahedirad1 , Adele Bahar * 1
1- Diabetes Research Center, Mazandaran University of Medical Sciences, Sari, Iran
Abstract:
Background: Over the past few decades, numerous studies have been conducted to explore the association between blood groups and thyroid disorders. However, thus far, the findings of these studies have been contradictory. This investigation aims to examine the prevalence of different blood groups among patients with thyroid disorders.
Material and Methods: This study was conducted on 1880 patients who had thyroid disorders including hypothyroidism, hyperthyroidism, and thyroid nodules with or without thyroid dysfunction. These patients were referred to the Endocrine Clinic of Sari in 1400. We extracted and recorded demographic information, which included age, sex, weight, and height, presence of thyroid nodule in ultrasound, needle aspiration, and the patient's blood type.
Results: Out of a total of 1880 individuals, 221 individuals (11.8%) were normal, 278 individuals (14.8%) were hyperthyroidism, and 1381 individuals (73.5%) were hypothyroidism. Among the patients, 26.4% of the total subjects had blood group B, 9.8% had blood group AB, 22.3% had blood group A, and 41.4% had blood group O. Furthermore, 8.6% of these individuals were Rh-negative. There was no significant association between thyroid disorders and blood group (P=0.94) as well as Rh (P=0.34). In addition, there was no significant association between thyroid nodule and blood group (P=0.40) and Rh (P=0.17), although a significant relationship was found between nodule and thyroid function (P=0.00001). Also, a significant association between malignancy and thyroid function (P=0.00001).
Conclusion: Individuals with O blood type exhibited a higher frequency of thyroid dysfunction and thyroid cancer compared to those with other blood types.
Material and Methods: This study was conducted on 1880 patients who had thyroid disorders including hypothyroidism, hyperthyroidism, and thyroid nodules with or without thyroid dysfunction. These patients were referred to the Endocrine Clinic of Sari in 1400. We extracted and recorded demographic information, which included age, sex, weight, and height, presence of thyroid nodule in ultrasound, needle aspiration, and the patient's blood type.
Results: Out of a total of 1880 individuals, 221 individuals (11.8%) were normal, 278 individuals (14.8%) were hyperthyroidism, and 1381 individuals (73.5%) were hypothyroidism. Among the patients, 26.4% of the total subjects had blood group B, 9.8% had blood group AB, 22.3% had blood group A, and 41.4% had blood group O. Furthermore, 8.6% of these individuals were Rh-negative. There was no significant association between thyroid disorders and blood group (P=0.94) as well as Rh (P=0.34). In addition, there was no significant association between thyroid nodule and blood group (P=0.40) and Rh (P=0.17), although a significant relationship was found between nodule and thyroid function (P=0.00001). Also, a significant association between malignancy and thyroid function (P=0.00001).
Conclusion: Individuals with O blood type exhibited a higher frequency of thyroid dysfunction and thyroid cancer compared to those with other blood types.
Type of Study: Research (Original) |
Subject:
Endocrinology
Published: 2023/12/28 | ePublished: 2023/12/28
Published: 2023/12/28 | ePublished: 2023/12/28
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
